MLN2480
CAS No. 1096708-71-2
MLN2480( TAK-580, TAK 580, TAK580, MLN 2480, MLN-2480, MLN2480 )
Catalog No. M17143 CAS No. 1096708-71-2
MLN2480 is an oral, selective pan-Raf kinase inhibitor in Clinicalal trials.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 61 | In Stock |
|
| 5MG | 95 | In Stock |
|
| 10MG | 170 | In Stock |
|
| 25MG | 286 | In Stock |
|
| 50MG | 422 | In Stock |
|
| 100MG | 620 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMLN2480
-
NoteResearch use only, not for human use.
-
Brief DescriptionMLN2480 is an oral, selective pan-Raf kinase inhibitor in Clinicalal trials.
-
DescriptionTAK-580, also known as MLN2480, BIIB024, and AMG 2112819, is an oral, selective pan-Raf kinase inhibitor. The Raf kinases (A-Raf, B-Raf and C-Raf) are key regulators of cell proliferation and survival within the mitogen-activated protein kinase (MAPK) pathway. The MAPK pathway is frequently disregulated in human cancers, often via activating mutations of Ras or Raf.
-
In Vitro——
-
In Vivo——
-
SynonymsTAK-580, TAK 580, TAK580, MLN 2480, MLN-2480, MLN2480
-
PathwayTGF-beta/Smad
-
TargetTGFBR
-
RecptorRaf
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1096708-71-2
-
Formula Weight506.29
-
Molecular FormulaC17H12Cl2F3N7O2S
-
Purity>98% (HPLC)
-
SolubilityDMSO : 50 mg/mL 98.76 mM;
-
SMILESNc1ncnc(C(=O)N[C@H](C)c2ncc(C(=O)Nc3ncc(Cl)c(C(F)(F)F)c3)s2)c1Cl
-
Chemical Name(R)-2-(1-(6-amino-5-chloropyrimidine-4-carboxamido)ethyl)-N-(5-chloro-4-(trifluoromethyl)pyridin-2-yl)thiazole-5-carboxamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1 Elizabeth Grace Carideo Cunniff, et al. Journal of Clinicalal Oncology 31, no. 15_suppl - published online before print.
molnova catalog
related products
-
Protein Kinase C 19-...
Protein Kinase C (19-31), a peptide inhibitor of protein kinase C (PKC), derived from the pseudo-substrate regulatory domain of PKCa (residues 19-31) with a serine at position 25 replacing the wild-type alanine, is used as protein kinase C substrate peptide for testing the protein kinase C activity.
-
GW-6604
A TGF-beta signaling pathway inhibitor that tagets ALK5.
-
A 83-01
A potent, selective TGF-beta type I receptor ALK-5, ALK-4 and ALK-7 inhibitor with IC50 of 12, 45 and 7.5 nM, respectively.
Cart
sales@molnova.com